Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine SupplyBusiness Wire • 12/20/21
Pfizer and BioNTech to provide more than 200 million additional COVID vaccine doses to EU in 2022Market Watch • 12/20/21
South African Study Shows Omicron Variant Could Escape Pfizer/BioNTech COVID-19 Vaccine ProtectionBenzinga • 12/14/21
Two doses of Pfizer's vaccine cut the risk of hospitalization by 70% during Omicron surge, real-world data from South Africa showedBusiness Insider • 12/14/21
Pfizer Shot Just 33% Effective Against Omicron Infection, But Largely Prevents Severe Disease, South Africa Study FindsForbes • 12/14/21
South Africa study shows two Pfizer shots may halt 70% of omicron hospitalizations: reportMarket Watch • 12/14/21
FDA Expands Emergency Use Of Pfizer/BioNTech's COVID-19 Booster To 16 Years & OlderBenzinga • 12/09/21
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and OlderBusiness Wire • 12/09/21
The FDA says 16- and 17-year-olds can now get a Pfizer vaccine booster shotBusiness Insider • 12/09/21